BioCentury
ARTICLE | Company News

Mitomics, QDx Pathology Services Inc. sales and marketing update

May 30, 2011 7:00 AM UTC

QDx received non-exclusive rights from Mitomics to develop and commercialize the mitochondrial marker behind Mitomics' prostate cancer diagnostic Prostate Core Mitomic Test (PCMT), which is used to d...